INTRA CELLULAR THERAPIES INC's ticker is and the CUSIP is 46116X901. A total of 3 filers reported holding INTRA CELLULAR THERAPIES INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $787,000 | +9.2% | 232 | -17.4% | 0.03% | -34.1% |
| Q3 2020 | $721,000 | -51.3% | 281 | -51.3% | 0.04% | -56.4% |
| Q2 2020 | $1,481,000 | -3.8% | 577 | +28.5% | 0.10% | -24.6% |
| Q4 2019 | $1,540,000 | +100.3% | 449 | -56.4% | 0.13% | +88.7% |
| Q3 2019 | $769,000 | +110.7% | 1,029 | +243.0% | 0.07% | +102.9% |
| Q1 2019 | $365,000 | – | 300 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 28,000 | $1,303,000 | 0.00% |
| JANE STREET GROUP, LLC | 120,900 | $5,625,000 | 0.00% |
| SIMPLEX TRADING, LLC | 20,900 | $972,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |